FDA Investigator Ruben C Ayala, PharmD

Ruben C Ayala, PharmD has inspections in 6 countries as of 29 Sep 2023. Ruben C Ayala, PharmD has collaborated with a combinined 2552 experts on various inspections, contributing to compliance and improvement across diverse sectors.

Investigator Details

Number of Inspected Sites:
24
Last Inspection Date:
29 Sep 2023
Investigator Role:
FDA Investigator
Redica ID:
Country:
India, Jordan, United States of America, United Kingdom of Great Britain and Northern Ireland, Israel, Mexico
Co-Investigator(s):
Alan A Rivera, Alan P Kurtzberg, Alanna Lmussawwir Bias, Alexander M Kay, Allan P Kurtzberg, Allen F Hall, Amanda E Lewin, PhD, Anthony E Keller, RPh, Anthony N Onianwa, Arindam Dasgupta, PhD, Azza Talaat, Barbara A Rusin, Barbara L Rogolsky, Barbara M Frazier, Barbara M Frezior, Bonita S Chester, Bruce H Mccullough, Camille D Brown, Carl A Huffman, III, Carl J Montgomery, Carmen Y Fisher, Chilton L Ng, Courtney N Long, Craig A Garmendia, Dandan Wang, PhD, Daniel L Aisen, David R Heiar, Dawn C Olenjack, Douglas A Campbell, Dr. Gopa Biswas, PhD, Dr. Sriram Subramaniam, PhD, Eric M Mueller, PharmD, Farhana Khan, Felix Maldonado, Gajendiran Mahadevan, PhD, Gene R Gunn, Geoffrey K Kilili, Gretchen Lf Trendel, Gulshan R Anand, Hasan A Irier, PhD, Hector J Colon Torres, Hyojong Kwon, PhD, Iraida Ortiz, Ivis Lnegron Torres, James R Fleckenstein, Janet B Abt, Janete F Guardia, Jeanne J Thai, Jennifer C Adams, Joanne M Schlossin, Joel D Martinez, Jogy George, John A Kadavil, PhD, John S Hartford, Jonathan R Campos, Joseph L Despins, PhD, Julie N Vosilus, Kara A Scheibner, PhD, Kathryn A Krentz, Kellia N Hicks, Kenneth M Gordon, Kevin A Gonzalez, Kimberly A Dux, Kip J Hanks, Kirstida Patel, Kirtida Patel, Lakecha N Lewis, Larry K Austin, Li Hongpaul Yeh, PhD, Linda R Kuchenthal, Lori A Gioia, Makini Cobourne Duval, PhD, Marc R Dickens, Marcus F Yambot, Margaret M Annes, Marian E Ramirez, Mark W Babbitt, Matthew C Watson, Matthew J Gretkierewicz, Meisha R Sampson, Meisha Waters, Michael A Charles, Michael S Araneta, Michele L Glendenning, Michele L Obert, Michele Perry Williams, Mohsen Rajabi Abhari, FDA, Mra Mcculloughj, Nancy A Bellamy, Nicola M Fenty Stewart, Nicole M Bell, Noreen Muniz, Paula J Bretz, Perry H Gambrell, Peter R Lenahan, Raymond T Oji, Rebecca T Davis, Regina T Brown, Richard H Penta, Rita K Kabaso, Robert J Doyle, Rochelle K Kimmel, Roger F Zabinski, Ronda R Loyd Jones, Sam H Haidar, PhD, Sandra S Saniga, Satheesh Thomas, Scott B Laufenberg, Sean R Marcsisin, Sherri N Rohlf, MD, Shirley H Isbill, Sripal R Mada, PhD, Srlram Subramaniam, PhD, Stephen D Brown, Steven M Weinman, Sunitha K Rajaram, PhD, Susanne M Richardson, MSc RAC ELS, Tawny L Colling, Thea C Grome, Thomas J Arista, Thomas W Gordon, Tiffani D Wilson, Timothy C Grome, Torrance J Slayton, Tracey L Harris, Uttaniti Limchumroon (Tom), Vickie J Kanion, Viviana Matta, Wayne D Mcgrath, Wayne T Smith, William J Leonard, Wr Bowman, Xiaohan Cai, PhD, Xikui Chen (nmi), PhD, Yiyue Zhang (nmi), PhD, Young M Choi, PhD, Yumi J Hiramine, Zerita White

Ruben C Ayala, PharmD's Documents

Publish Date Document Type Title
April, 2015 FDA 483 Synchron Research Services Private Limited - Form 483, 2015-04-03
June, 2016 FDA 483 KCAS, LLC - Form 483, 2016-06-24
November, 2016 FDA 483 International Pharmaceutical Research Center - Form 483, 2016-11-03
November, 2013 FDA 483 Sun Pharmaceutical Industries Limited - Form 483, 2013-11-22
June, 2016 EIR KCAS, LLC - EIR, 2016-06-24
August, 2014 FDA 483 KCAS, LLC - Form 483, 2014-08-29

Experience Redica System's NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.


Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more